Literature DB >> 9159237

Invasion of human glioma: role of extracellular matrix proteins.

S K Chintala1, J K Rao.   

Abstract

The invasion of glioma into normal brain tissue is a major challenge to clinical intervention because these tumors often highly infiltrate the surrounding brain tissue. Total surgical resection of gliomas is impossible, and recurrence of tumor growth is a common phenomenon; patients have a mean survival time of 8-12 months. Although in recent years substantial progress has been made toward understanding the invasive behavior of gliomas in vitro and in vivo, the factors responsible for the extensive infiltration are still poorly documented. This review focuses on recent research concerning the invasion of gliomas, as well as the extracellular matrix components, and the proteolytic enzymes involved. A better understanding of cell-matrix interactions will help in developing therapeutic strategies to decrease the invasion of gliomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9159237     DOI: 10.2741/a135

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  9 in total

1.  RUNX1 Regulates Migration, Invasion, and Angiogenesis via p38 MAPK Pathway in Human Glioblastoma.

Authors:  Kant Sangpairoj; Pornpun Vivithanaporn; Somjai Apisawetakan; Sukumal Chongthammakun; Prasert Sobhon; Kulathida Chaithirayanon
Journal:  Cell Mol Neurobiol       Date:  2016-12-24       Impact factor: 5.046

2.  Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection.

Authors:  C-S Hong; W Fellows; A Niranjan; S Alber; S Watkins; J B Cohen; J C Glorioso; P Grandi
Journal:  Gene Ther       Date:  2010-05-13       Impact factor: 5.250

3.  Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.

Authors:  József Virga; László Bognár; Tibor Hortobágyi; Gábor Zahuczky; Éva Csősz; Gergő Kalló; Judit Tóth; Gábor Hutóczki; Judit Reményi-Puskár; László Steiner; Almos Klekner
Journal:  Pathol Oncol Res       Date:  2017-02-04       Impact factor: 3.201

4.  Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation.

Authors:  Senija Behrem; Kamelija Zarković; Neven Eskinja; Nives Jonjić
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

Review 5.  Identifying new small molecule anti-invasive compounds for glioma treatment.

Authors:  Jennifer Munson; Michael Bonner; Levi Fried; Jonathan Hofmekler; Jack Arbiser; Ravi Bellamkonda
Journal:  Cell Cycle       Date:  2013-07-15       Impact factor: 4.534

6.  Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-κB activation.

Authors:  Tao Tao; Chun Cheng; Yuhong Ji; Guangfei Xu; Jianguo Zhang; Li Zhang; Aiguo Shen
Journal:  Mol Biol Cell       Date:  2012-05-16       Impact factor: 4.138

7.  Compound K attenuates stromal cell-derived growth factor 1 (SDF-1)-induced migration of C6 glioma cells.

Authors:  Hyuck Kim; Hyo Sun Roh; Jai Eun Kim; Sun Dong Park; Won Hwan Park; Jin-Young Moon
Journal:  Nutr Res Pract       Date:  2016-03-02       Impact factor: 1.926

Review 8.  Radiation-Induced Alterations in the Recurrent Glioblastoma Microenvironment: Therapeutic Implications.

Authors:  Kshama Gupta; Terry C Burns
Journal:  Front Oncol       Date:  2018-11-08       Impact factor: 6.244

9.  Identification of TNFAIP6 as a hub gene associated with the progression of glioblastoma by weighted gene co-expression network analysis.

Authors:  Dongdong Lin; Wei Li; Nu Zhang; Ming Cai
Journal:  IET Syst Biol       Date:  2022-06-29       Impact factor: 1.468

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.